Advertisement
 
YOU ARE HERE: LAT HomeCollectionsNih
IN THE NEWS

Nih

CALIFORNIA | LOCAL
December 6, 2006 | Susannah Rosenblatt, Times Staff Writer
Los Angeles County supervisors unanimously backed emergency efforts Tuesday to save an AIDS treatment program that has provided cutting-edge medication to uninsured and largely minority patients for two decades, after the National Institutes of Health announced plans to end millions in funding. Of 33 such clinical trial sites nationwide, the local clinic is reportedly among at least eight whose research grants are not being renewed.
Advertisement
NATIONAL
December 5, 2006 | David Willman, Times Staff Writer
Federal prosecutors on Monday charged a senior scientist at the National Institutes of Health with conflict of interest for taking $285,000 in fees from a drug company that was involved with his government research. Dr. P. Trey Sunderland III is the first official in 14 years to be prosecuted for conflict of interest at the NIH, an agency rocked in recent years by revelations of widespread financial ties to the drug industry. Sunderland accepted the fees from 1998 to 2003 from Pfizer Inc.
NATIONAL
September 14, 2006 | David Willman, Times Staff Writer
A congressional subcommittee chairman and a top administrator of the National Institutes of Health agreed on at least one point Wednesday: Private financial deals between drug companies and NIH scientists that have come to light in recent years have posed the worst scandal in the agency's history. "This is the largest scandal in all of the NIH's existence," said Rep. Edward Whitfield (R-Ky.), chairman of the House Energy and Commerce subcommittee on investigations.
NATIONAL
September 10, 2006 | David Willman, Times Staff Writer
A senior researcher at the National Institutes of Health engaged in "serious misconduct" by entering into dozens of unauthorized private arrangements with drug companies and failing to report annually the outside income, totaling more than $100,000, a confidential internal review by the agency has found. Officials at the NIH concluded late last year that the actions of Dr. Thomas J.
CALIFORNIA | LOCAL
August 22, 2006 | Christian Berthelsen, Times Staff Writer
The National Institutes of Health have reopened an inquiry into the activities of two UC Irvine psychiatrists in the wake of a report in The Times that they skirted the school's patient safety review board to test a drug without permission from the university. The NIH, the primary government agency for funding of medical research, previously had looked into the drug company test by Steven G. Potkin and William E. "Biff" Bunney in 2005 after it received an anonymous complaint.
NATIONAL
August 10, 2006 | David Willman, Times Staff Writer
A bipartisan group of congressional leaders has asked the director of the National Institutes of Health to provide details of a senior researcher's ties to several pharmaceutical companies. The congressional leaders, including the Republican chairman and the ranking Democrat of the House Energy and Commerce Committee, said in their letter that they wanted the details in order to evaluate conflict-of-interest policies at the NIH. They requested a response by week's end.
NATIONAL
July 16, 2006 | David Willman, Times Staff Writer
Dr. Thomas J. Walsh, a physician-researcher for the National Institutes of Health, has added to his income and bolstered his lab with checks from drug companies, according to interviews and government records. The NIH would not comment on Walsh's relationship with industry, including whether he had obtained permission for outside work or had reported the income.
NATIONAL
June 15, 2006 | David Willman, Times Staff Writer
A senior scientist at the National Institutes of Health exercised his right against self-incrimination Wednesday, refusing to answer questions from a congressional subcommittee investigating conflicts of interest at the agency. Dr. P. Trey Sunderland III, who remains chief of the geriatric psychology branch at the NIH's National Institute of Mental Health, had accepted hundreds of thousands of dollars in fees from Pfizer Inc. while collaborating with the company in his government role.
NATIONAL
June 14, 2006 | David Willman, Times Staff Writer
A senior Alzheimer's disease researcher at the National Institutes of Health pocketed more than $600,000 in fees from Pfizer Inc. while providing the drug company with thousands of samples of spinal fluid drawn from patients who were studied for his government work, congressional investigators said in a report made public Tuesday. The new details about the conduct of the scientist, Dr. P.
NATIONAL
December 24, 2005 | From Associated Press
Reversing course, the government's premier health research agency has reinstated a medical safety expert who was fired after raising allegations of scientific misconduct and sexual harassment in federal AIDS research, his lawyer said Friday. The National Institutes of Health's reinstatement of Dr. Jonathan Fishbein settles a two-year battle that prompted congressional and federal investigations.
Los Angeles Times Articles
|